<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32504811</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1519</ISSN><JournalIssue CitedMedium="Internet"><Volume>279</Volume><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Respiratory physiology &amp; neurobiology</Title><ISOAbbreviation>Respir Physiol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>5-HT2A/B receptor expression in the phrenic motor nucleus in a rat model of ALS (SOD1<sup>G93A</sup>).</ArticleTitle><Pagination><StartPage>103471</StartPage><MedlinePgn>103471</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resp.2020.103471</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1569-9048(20)30129-4</ELocationID><Abstract><AbstractText>Despite respiratory motor neuron death, ventilation is preserved in SOD1<sup>G93A</sup> rats. Compensatory respiratory plasticity may counterbalance the loss of these neurons. Phrenic long-term facilitation (pLTF; a form of respiratory plasticity) in na&#xef;ve rats is 5-HT2 and NADPH oxidase-dependent. Furthermore, 5-HT2A, not 5-HT2B, receptor-induced phrenic motor facilitation is NADPH oxidase-independent in na&#xef;ve rats. pLTF is NADPH oxidase-dependent in pre-symptomatic, but not end-stage, SOD1<sup>G93A</sup> rats. Here, we hypothesized that in the putative phrenic motor nucleus (PMN) of SOD1<sup>G93A</sup> rats vs. wild-type littermates: 1) pre-symptomatic rats would have greater 5-HT2B receptor expression that decreases at end-stage; and 2) 5-HT2A receptor expression would increase from pre-symptomatic to end-stage. Putative PMN 5-HT2A receptor expression was reduced when comparing across (but not within) pre-symptomatic vs. end-stage groups (p &lt; 0.05). In contrast, putative PMN 5-HT2B receptor expression was increased when comparing across pre-symptomatic vs. end-stage groups, and within end-stage groups (p &lt; 0.05). These data suggest a potential role for 5-HT2 receptors in pLTF and breathing in SOD1<sup>G93A</sup> rats.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borkowski</LastName><ForeName>Lauren F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 65211, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craig</LastName><ForeName>Taylor A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 65211, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stricklin</LastName><ForeName>Olivia E</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 65211, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Katherine A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 65211, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nichols</LastName><ForeName>Nicole L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 65211, United States. Electronic address: nicholsn@missouri.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K99 HL119606</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 HL119606</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Respir Physiol Neurobiol</MedlineTA><NlmUniqueID>101140022</NlmUniqueID><ISSNLinking>1569-9048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044402">Receptor, Serotonin, 5-HT2A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044403">Receptor, Serotonin, 5-HT2B</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000870" MajorTopicYN="N">Anterior Horn Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058070" MajorTopicYN="N">Asymptomatic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002574" MajorTopicYN="N">Cervical Vertebrae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003964" MajorTopicYN="N">Diaphragm</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="Y">innervation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017774" MajorTopicYN="N">Long-Term Potentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010791" MajorTopicYN="Y">Phrenic Nerve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044402" MajorTopicYN="N">Receptor, Serotonin, 5-HT2A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044403" MajorTopicYN="N">Receptor, Serotonin, 5-HT2B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Breathing</Keyword><Keyword MajorTopicYN="N">Plasticity</Keyword><Keyword MajorTopicYN="N">Respiratory motor neuron</Keyword><Keyword MajorTopicYN="N">Serotonin</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest All authors declare no con&#xfb02;icts of interest, &#xfb01;nancial or otherwise in relation to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32504811</ArticleId><ArticleId IdType="mid">NIHMS1605132</ArticleId><ArticleId IdType="pmc">PMC7384973</ArticleId><ArticleId IdType="doi">10.1016/j.resp.2020.103471</ArticleId><ArticleId IdType="pii">S1569-9048(20)30129-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersen PM, Sims KB, Xin WW, Kiely R, O&#x2019;Neill G, Ravits J, Pioro E, Harati Y, Brower RD, Levine JS &amp; Heinicke HU (2003). Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotrophic lateral sclerosis and other motor neuron disorders, 4(2), 62&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">14506936</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach KB, &amp; Mitchell GS (1996). Hypoxia-induced long-term facilitation of respiratory activity is serotonin dependent. Respiration physiology, 104(2&#x2013;3), 251&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">8893371</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker-Herman TL, Fuller DD, Bavis RW, Zabka AG, Golder FJ, Doperalski NJ, Johnson RA, Watters JJ, &amp; Mitchell GS (2004). BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nature neuroscience, 7(1), 48.</Citation><ArticleIdList><ArticleId IdType="pubmed">14699417</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Velde CV, &amp; Cleveland DW (2006). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 52(1), 39&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulenguez P, Gestreau C, Vinit S, Stamegna JC, Kastner A, &amp; Gauthier P (2007). Specific and artifactual labeling in the rat spinal cord and medulla after injection of monosynaptic retrograde tracers into the diaphragm. Neuroscience letters, 417(2), 206&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">17412505</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke SC, Shaw PJ, &amp; Gibson GJ (2001). Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS. Neurology, 57(11), 2040&#x2013;2044.</Citation><ArticleIdList><ArticleId IdType="pubmed">11739823</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe9;ard M, &amp; Grillon C (2009). Serotonin binds to purified neuronal nitric oxide synthase: a possible explanation for ROS production induced by 5HT in the presence of nNOS. Free radical research, 43(3), 206&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">19191108</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, &amp; Cleveland DW (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18(2), 327&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale EA, Nashold LJ, Mahamed S, Svendsen CN, &amp; Mitchell GS (2006). Sustained ventilatory capacity in a rat model of amyotrophic lateral sclerosis (ALS). A1213&#x2013;A1213.</Citation></Reference><Reference><Citation>Dale-Nagle EA, Hoffman MS, MacFarlane PM, &amp; Mitchell GS (2010). Multiple pathways to long-lasting phrenic motor facilitation New frontiers in respiratory control (pp. 225&#x2013;230). Springer, New York, NY.</Citation></Reference><Reference><Citation>Dentel C, Palamiuc L, Henriques A, Lannes B, Spreux-Varoquaux O, Gutknecht L, Ren&#xe9; F, Echaniz-Laguna A, Gonzalez de Aguilar JL, Lesch KP and Meininger V (2012). Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity. Brain, 136(2), 483&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">23114367</ArticleId></ArticleIdList></Reference><Reference><Citation>Devinney MJ, Fields DP, Huxtable AG, Peterson TJ, Dale EA, &amp; Mitchell GS (2015). Phrenic long-term facilitation requires PKC&#x3b8; activity within phrenic motor neurons. Journal of Neuroscience, 35(21), 8107&#x2013;8117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4444536</ArticleId><ArticleId IdType="pubmed">26019328</ArticleId></ArticleIdList></Reference><Reference><Citation>El Oussini H, Bayer H, Scekic-Zahirovic J, Vercruysse P, Sinniger J, Dirrig-Grosch S, Dieterl&#xe9; S, Echaniz-Laguna A, Larmet Y, M&#xfc;ller K &amp; Weishaupt JH (2016). Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis. Acta neuropathologica, 131(3), 465&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">26744351</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman JL, Mitchell GS, &amp; Nattie EE (2003). Breathing: rhythmicity, plasticity, chemosensitivity. Annual review of neuroscience, 26(1), 239&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2811316</ArticleId><ArticleId IdType="pubmed">12598679</ArticleId></ArticleIdList></Reference><Reference><Citation>Fouad K, Rank MM, Vavrek R, Murray KC, Sanelli L, &amp; Bennett DJ (2010). Locomotion after spinal cord injury depends on constitutive activity in serotonin receptors. Journal of neurophysiology, 104(6), 2975&#x2013;2984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3007654</ArticleId><ArticleId IdType="pubmed">20861436</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuller DD, Zabka AG, Baker TL, &amp; Mitchell GS (2001). Selected contribution: phrenic long-term facilitation requires 5-HT receptor activation during but not following episodic hypoxia. Journal of applied physiology, 90(5), 2001&#x2013;2006.</Citation><ArticleIdList><ArticleId IdType="pubmed">11299296</ArticleId></ArticleIdList></Reference><Reference><Citation>Golder FJ, Ranganathan L, Satriotomo I, Hoffman M, Lovett-Barr MR, Watters JJ, Baker-Herman TL, &amp; Mitchell GS (2008). Spinal adenosine A2a receptor activation elicits long-lasting phrenic motor facilitation. Journal of Neuroscience, 28(9), 2033&#x2013;2042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671860</ArticleId><ArticleId IdType="pubmed">18305238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW and Deng HX (1994). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 264(5166), 1772&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi F, Hinrichsen CFL, &amp; McCrimmon DR (2003). Short-term plasticity of descending synaptic input to phrenic motoneurons in rats. Journal of applied physiology, 94(4), 1421&#x2013;1430.</Citation><ArticleIdList><ArticleId IdType="pubmed">12482770</ArticleId></ArticleIdList></Reference><Reference><Citation>Heckman CJ, Mottram C, Quinlan K, Theiss R, &amp; Schuster J (2009). Motoneuron excitability: the importance of neuromodulatory inputs. Clinical Neurophysiology, 120(12), 2040&#x2013;2054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7312725</ArticleId><ArticleId IdType="pubmed">19783207</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirst WD, Cheung NY, Rattray M, Price GW, &amp; Wilkin GP (1998). Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes, without functional coupling of 5-HT1 receptor subtypes to adenylyl cyclase. Molecular brain research, 61(1&#x2013;2), 90&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">9795156</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman MS, Nichols NL, MacFarlane PM, &amp; Mitchell GS (2012). Phrenic long-term facilitation after acute intermittent hypoxia requires spinal ERK activation but not TrkB synthesis. Journal of applied physiology, 113(8), 1184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472488</ArticleId><ArticleId IdType="pubmed">22961271</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, &amp; DeGennaro LJ (2002). Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proceedings of the National Academy of Sciences, 99(3), 1604&#x2013;1609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122237</ArticleId><ArticleId IdType="pubmed">11818550</ArticleId></ArticleIdList></Reference><Reference><Citation>Krabbe G, Matyash V, Pannasch U, Mamer L, Boddeke HW, &amp; Kettenmann H (2012). Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity. Brain, behavior, and immunity, 26(3), 419&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">22198120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechtzin N, Rothstein J, Clawson L, Diette GB, &amp; Wiener CM (2002). Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment. Amyotrophic Lateral Sclerosis and other motor neuron disorders, 3(1), 5&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">12061943</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lillo C, Jonsson PA, Velde CV, Ward CM, Miller TM, Subramaniam JR, Rothstein JD, Marklund S, Andersen PM, &amp; Br&#xe4;nnstr&#xf6;m T (2004). Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron, 43(1), 5&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyall RA, Donaldson N, Polkey MI, Leigh PN, &amp; Moxham J (2001). Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain, 124(10), 2000&#x2013;2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">11571218</ArticleId></ArticleIdList></Reference><Reference><Citation>MacFarlane PM, &amp; Mitchell GS (2009). Episodic spinal serotonin receptor activation elicits long-lasting phrenic motor facilitation by an NADPH oxidase-dependent mechanism. The Journal of physiology, 587(22), 5469&#x2013;5481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2793877</ArticleId><ArticleId IdType="pubmed">19805745</ArticleId></ArticleIdList></Reference><Reference><Citation>MacFarlane PM, &amp; Mitchell GS (2009). Spinal nitric oxide synthase activity is necessary for phrenic long-term facilitation following intermittent hypoxia.</Citation></Reference><Reference><Citation>MacFarlane PM, Vinit S, &amp; Mitchell GS (2011). Serotonin 2A and 2B receptor-induced phrenic motor facilitation: differential requirement for spinal NADPH oxidase activity. Neuroscience, 178, 45&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3072788</ArticleId><ArticleId IdType="pubmed">21223996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantilla CB, Zhan WZ, &amp; Sieck GC (2009). Retrograde labeling of phrenic motoneurons by intrapleural injection. Journal of neuroscience methods, 182(2), 244&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2727569</ArticleId><ArticleId IdType="pubmed">19559048</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcusson JO, Morgan DG, Winblad B and Finch CE (1984). Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Research, 311(1), pp.51&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">6488044</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuire M, &amp; Ling L (2004). Activation of protein kinase C near/in phrenic motoneurons is required for phrenic long-term facilitation in rats. Am J Respir Crit Care Med, 169(7), A433.</Citation></Reference><Reference><Citation>Murray KC, Stephens MJ, Ballou EW, Heckman CJ, &amp; Bennett DJ (2010). Motoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity. Journal of neurophysiology, 105(2), 731&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059173</ArticleId><ArticleId IdType="pubmed">20980537</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray KC, Nakae A, Stephens MJ, Rank M, D&#x2019;amico J, Harvey PJ, Li X, Harris RLW, Ballou EW, Anelli R and Heckman CJ (2010). Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT 2C receptors. Nature medicine, 16(6), 694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3107820</ArticleId><ArticleId IdType="pubmed">20512126</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N, Brown RH, &amp; Itoyama Y (2001). Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. Journal of Neuroscience, 21(23), 9246&#x2013;9254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763929</ArticleId><ArticleId IdType="pubmed">11717358</ArticleId></ArticleIdList></Reference><Reference><Citation>Neverova NV, Saywell SA, Nashold LJ, Mitchell GS, &amp; Feldman JL (2007). Episodic stimulation of &#x3b1;1-adrenoreceptors induces protein kinase C-dependent persistent changes in motoneuronal excitability. Journal of Neuroscience, 27(16), 4435&#x2013;4442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6672307</ArticleId><ArticleId IdType="pubmed">17442828</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols NL, Craig TA, &amp; Tanner MA (2018). Phrenic long-term facilitation following intrapleural CTB-SAP-induced respiratory motor neuron death. Respiratory physiology &amp; neurobiology, 256, 43&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5815965</ArticleId><ArticleId IdType="pubmed">28822818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols NL, Gowing G, Satriotomo I, Nashold LJ, Dale EA, Suzuki M, Avalos P, Mulcrone PL, McHugh J, Svendsen CN and Mitchell GS (2013). Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis. American journal of respiratory and critical care medicine, 187(5), 535&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733409</ArticleId><ArticleId IdType="pubmed">23220913</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols NL, Johnson RA, Satriotomo I, &amp; Mitchell GS (2014). Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS rats. Respiratory physiology &amp; neurobiology, 197, 19&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4022482</ArticleId><ArticleId IdType="pubmed">24681328</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols NL, Satriotomo I, Allen LL, Grebe AM &amp; Mitchell GS (2017). Mechanisms of enhanced phrenic long-term facilitation in SOD1G93A rats. J. Neurosci. 37(24), 5834&#x2013;5845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5473203</ArticleId><ArticleId IdType="pubmed">28500219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols NL, Satriotomo I, Harrigan DJ, &amp; Mitchell GS (2015). Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS. Experimental neurology, 273, 138&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4644466</ArticleId><ArticleId IdType="pubmed">26287750</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols NL, Vinit S, Bauernschmidt L, &amp; Mitchell GS (2015). Respiratory function after selective respiratory motor neuron death from intrapleural CTB&#x2013;saporin injections. Experimental neurology, 267, 18&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4417059</ArticleId><ArticleId IdType="pubmed">25476493</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O&#x2019;Regan JP, Deng HX, &amp; Rahmani Z (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362(6415), 59.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadjalli A, &amp; Mitchell GS (2019). Cervical Spinal 5-HT2A and 5-HT2B receptors are both necessary for moderate acute intermittent hypoxia-induced phrenic long-term facilitation. Journal of Applied Physiology. 127(2), 432&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6732436</ArticleId><ArticleId IdType="pubmed">31219768</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadros SF, D&#x2019;Souza M, Zettel ML, Zhu X, Lynch-Erhardt M and Frisina RD, (2007). Serotonin 2B receptor: upregulated with age and hearing loss in mouse auditory system. Neurobiology of aging, 28(7), pp. 1112&#x2013;1123.</Citation><ArticleIdList><ArticleId IdType="pubmed">16822592</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankersley CG, Haenggeli C, &amp; Rothstein JD (2007). Respiratory impairment in a mouse model of amyotrophic lateral sclerosis. Journal of applied physiology, 102(3), 926&#x2013;932.</Citation><ArticleIdList><ArticleId IdType="pubmed">17110520</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou SY, Basura GJ, &amp; Goshgarian HG (2001). Serotonin 2 receptors mediate respiratory recovery after cervical spinal cord hemisection in adult rats. Journal of applied physiology, 91(6), 2665&#x2013;2673.</Citation><ArticleIdList><ArticleId IdType="pubmed">11717232</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, &amp; Price DL (1995). An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14(6), 1105&#x2013;1116.</Citation><ArticleIdList><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, Copeland NG, Jenkins NA, &amp; Borchelt DR (2003). Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Human molecular genetics, 12(21), 2753&#x2013;2764.</Citation><ArticleIdList><ArticleId IdType="pubmed">12966034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang GJ, Volkow ND, Logan J, Fowler JS, Schlyer D, MacGregor RR, Hitzemann RJ, Gur RC and Wolf AP (1995). Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. Life sciences, 56(14), pp.PL249&#x2013;PL253.</Citation><ArticleIdList><ArticleId IdType="pubmed">7475891</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson C, Paxinos G, Kayalioglu G (2009). The spinal cord: a Christopher and Dana Reeve Foundation text and atlas. London: Academic.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>